JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

The Journal of Enzyme Inhibition and Medicinal Chemistry (ISSN 1475-6366) is a reputable international bi-monthly publication issued by Taylor & Francis in the United Kingdom, dedicated to advancing research at the intersection of enzymology and medicinal chemistry. As an SCI-indexed journal, it maintains a strong academic standing, evidenced by its steadily rising impact factor, which reached 5.6 in 2022, and its classification in the third quartile of the medical sciences category within the Chinese Academy of Sciences journal ranking system. The journal publishes high-quality peer-reviewed studies focusing on the design, synthesis, and mechanistic elucidation of enzyme inhibitors, with a particular emphasis on their application in drug discovery for critical therapeutic areas such as oncology, infectious diseases, inflammatory conditions, and neurodegenerative disorders. Operating under a hybrid open-access model, the journal offers authors the option to make their work freely available while maintaining a rigorous editorial process that ensures scientific integrity. Consequently, it serves as a valuable platform for researchers in the pharmaceutical and chemical sciences seeking to disseminate impactful findings in enzyme-targeted drug development.